Work together with stakeholders to build a healthy China
Rooted in China for more than 30 years, Pfizer has become one of the most important foreign pharmaceutical companies in China. Advanced new Pfizer will continue to contribute to the realization of "Healthy China 2030".
Since entering the Chinese market in 1989, Pfizer has operated in China for over 30 years and now has become one of the leading foreign pharmaceutical companies in China. So far, Pfizer has invested over 1.5 billion USD in China, with a presence in over 300 cities nationwide and a total staff of almost 7,000 covering the business, R&D and manufacturing in China. Pfizer has established 1 state-of-the-art manufacturing facility and 2 R&D centers (in Shanghai Zhangjiang High-Tech Park and Wuhan Biolake – the national biological industrial base respectively). We have introduced high-quality innovative drugs into China, covering 5 major disease areas, including the drugs and vaccines for oncology, vaccines, anti-infectives, inflammation & immunology and rare disease. Our strong product lines are developed to meet the diverse needs in every stage of life.
Rooted in China for more than 30 years, Pfizer has continuously introduced more core technologies and resources into China, and actively promoted the development of China's health industry by leveraging its global medical resources.
Pfizer established the first China-based plant in Dalian, which was the first GMP-certified pharmaceutical plant in China.
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Pfizer established the pharmaceutical plant in Wuxi.
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Pfizer set up the Management Center in Beijing.
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Pfizer established Pfizer Investment Co., Ltd. in Shanghai.
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Pfizer established Pfizer China R&D Center in Shanghai.
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Pfizer established Pfizer Finance Share Service (Asia-Pacific).
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Pfizer established the R&D Center at Wuhan Biolake.
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Pfizer China reported to Pfizer Corporate directly, further highlighting the emphasis on the Chinese market.
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.
Pfizer starts the new journey. Pfizer is becoming a science-based, innovative and patient-focused biopharmaceutical company.
Etiam vel malesuada eros, feugiat augue. Sed posuere mi sed pulvinar, eleifend varius augue Proin eleifend ultricies ligula iaculis. In in dapibus lorem, vel sodals.